Important note: Information in this article was accurate in 2007. The state of the art may have changed since the publication date.
|
|
Business Day (Johannesburg) (12.18.07) - Wednesday, December 19, 2007
Tamar Kahn
The findings are based on HIV test results from pregnant women attending public clinics, said Pierre Uys of the provincial health department. In line with South Africa's national antenatal survey of HIV and syphilis prevalence, Western Cape reported a small drop in HIV between 2005 and last year, from 15.7 percent to 15.1 percent. The national rate was nearly double that of Western Cape, with HIV prevalence decreasing slightly from 30.2 percent to 29.1 percent. For women under age 24 in the province, HIV prevalence fell from 12.8 percent to 11.9 percent.
Western Cape women ages 25-29 posted the largest increase over the past decade, with HIV prevalence among this group rising from 7.9 percent in 1997 to 21.1 percent last year.
Several health districts recorded an increase in HIV. In Helderberg, prevalence increased from 12.8 percent in 2005 to 17.3 percent last year. Similarly, Oostenberg's rate increased over the past three years, from 14.8 percent in 2004 to 18.8 percent last year.
"High-prevalence areas require additional energy and resources," said Uys. "We really want programs that address local issues. For example, in Khayelitsha we now have programs targeting older men. We have already targeted schools, and we want to get peer-educator [HIV] programs into all of them."
In addition, the health department has created programs aimed at sex workers and truckers, said Uys.
071219
AD072644
Copyright © 2007 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
.